title: Azacitidine: a new medication associated with Sweet syndrome.
authors.forename: Suzanne
authors.initials: S
authors.lastname: Tintle
authors.forename: Vishal
authors.initials: V
authors.lastname: Patel
authors.forename: Andrea
authors.initials: A
authors.lastname: Ruskin
authors.forename: Charles
authors.initials: C
authors.lastname: Halasz
mesh_terms: D000368:Aged; D001374:Azacitidine / Q000008:administration & dosage / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology*; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007262:Infusions, Intravenous; D007279:Injections, Subcutaneous; D008297:Male; D009190:Myelodysplastic Syndromes / Q000188:drug therapy* / Q000276:immunology; D012008:Recurrence; D016463:Sweet Syndrome / Q000139:chemically induced* / Q000175:diagnosis / Q000276:immunology
chemical_list: D004791:Enzyme Inhibitors; D001374:Azacitidine